TrialPanorama/TrialPanorama-database huggingface dataset:
Study: 15063053

Group type: EXPERIMENTAL
Intervention: Postural coordination during reading task on various surfaces
Number of subjects: 31

Group type: EXPERIMENTAL
Intervention: Postural sway (head motion)
Number of subjects: 31
Study: 11593322

Group type: EXPERIMENTAL
Intervention: Weekly CMV antigenemia testing with ganciclovir administration for a positive result
Number of subjects: 118

Group type: COMPARATOR
Intervention: Bronchoscopy for CMV on day 35 post BMT
Number of subjects: 118

Group type: COMPARATOR
Intervention: Bronchoscopy arm
Number of subjects: 118

Group type: EXPERIMENTAL
Intervention: Antigenemia arm
Number of subjects: 118
Study: 10186958

Group type: EXPERIMENTAL
Intervention: 2-minute treatment of concentrated (5 mg/mL) albuterol in the Circulaire nebulizer
Number of subjects: 0

Group type: COMPARATOR
Intervention: Conventional unit dose treatment
Number of subjects: 0
Study: 8115670

Group type: EXPERIMENTAL
Intervention: Haloperidol (10, 20 or 30 mg/day for three weeks)
Number of subjects: 20
Study: 3398512

Group type: EXPERIMENTAL
Intervention: Walking at a pace that elicited 60% of V̇O2max, for 30 minutes, three times weekly for twelve weeks.
Number of subjects: 26

Group type: COMPARATOR
Intervention: Control group (not specified in detail).
Number of subjects: 26
Study: 29411268

Group type: EXPERIMENTAL
Intervention: Cysteamine Bitartrate Delayed-Release (CBDR) capsules with orange juice
Number of subjects: 32

Group type: EXPERIMENTAL
Intervention: Cysteamine Bitartrate Delayed-Release (CBDR) capsules with water
Number of subjects: 32

Group type: EXPERIMENTAL
Intervention: Cysteamine Bitartrate Delayed-Release (CBDR) capsules with omeprazole 20 mg and water
Number of subjects: 32

Group type: EXPERIMENTAL
Intervention: Omeprazole co-administration
Number of subjects: 32

Group type: COMPARATOR
Intervention: All treatments (orange juice, water, omeprazole)
Number of subjects: 32
Study: 27029778

Group type: EXPERIMENTAL
Intervention: FTC-TDF
Number of subjects: 1549

Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 1549
Study: 24738463

Group type: EXPERIMENTAL
Intervention: Early removal of urethral catheter (1-2 days)
Number of subjects: 128

Group type: COMPARATOR
Intervention: Control group (catheter removal at 5-7 days)
Number of subjects: 128
Study: 23431246

Group type: EXPERIMENTAL
Intervention: HE3286
Number of subjects: 0

Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 0
Study: 20735398

Group type: EXPERIMENTAL
Intervention: R-CHOP (rituximab, cyclophosphamide, doxorubicin, vincristine and prednisone)
Number of subjects: 267

Group type: EXPERIMENTAL
Intervention: E-IPI
Number of subjects: 267

Group type: EXPERIMENTAL
Intervention: R-IPI
Number of subjects: 267
Study: 19244630

Group type: COMPARATOR
Intervention: Droperidol 5 mg IM
Number of subjects: 87

Group type: EXPERIMENTAL
Intervention: Olanzapine 10 mg IM
Number of subjects: 87
Study: 16318615

Group type: EXPERIMENTAL
Intervention: Glyburide
Number of subjects: 70

Group type: EXPERIMENTAL
Intervention: Acarbose
Number of subjects: 70

Group type: EXPERIMENTAL
Intervention: Insulin
Number of subjects: 70
Study: 12622339

Group type: EXPERIMENTAL
Intervention: Combined administration of 0.65 g/kg alcohol and 4 mg/kg caffeine
Number of subjects: 21

Group type: COMPARATOR
Intervention: 0.65 g/kg alcohol alone
Number of subjects: 21

Group type: COMPARATOR
Intervention: 4 mg/kg caffeine alone
Number of subjects: 21
Study: 10589107

Group type: EXPERIMENTAL
Intervention: Intervention strategy using a geropsychiatric nurse and trained older adult volunteers
Number of subjects: 139

Group type: COMPARATOR
Intervention: Control group (not specified)
Number of subjects: 139
Study: 8743003

Group type: EXPERIMENTAL
Intervention: 2% dorzolamide thrice daily
Number of subjects: 16

Group type: COMPARATOR
Intervention: 0.5% timolol twice daily
Number of subjects: 16

Group type: COMPARATOR
Intervention: 0.5% betaxolol twice daily
Number of subjects: 16
Study: 1889719

Group type: EXPERIMENTAL
Intervention: Ranitidine, 150 mg nightly (continuous dosing)
Number of subjects: 17

Group type: COMPARATOR
Intervention: Ranitidine, 150 mg nightly (intermittent dosing)
Number of subjects: 17

Group type: EXPERIMENTAL
Intervention: Both intermittent and continuous dosing with ranitidine
Number of subjects: 17
Study: 6614662

Group type: EXPERIMENTAL
Intervention: Intravenous and/or oral potassium chloride supplementation during preoperative bowel preparation (60 mmol average supplementation)
Number of subjects: 53

Group type: COMPARATOR
Intervention: No potassium chloride supplementation
Number of subjects: 53
Study: 31335755

Group type: EXPERIMENTAL
Intervention: Ketamine/propofol admixture (0.5 mg/kg of ketamine and propofol each)
Number of subjects: 160

Group type: COMPARATOR
Intervention: Etomidate (0.15 mg/kg)
Number of subjects: 160
Study: 29519598

Group type: EXPERIMENTAL
Intervention: Bony fixation with Kirschner (K-) wire
Number of subjects: 55

Group type: COMPARATOR
Intervention: Suture fixation
Number of subjects: 55
Study: 27179770

Group type: EXPERIMENTAL
Intervention: Combined group (IV and topical TXA)
Number of subjects: 84

Group type: COMPARATOR
Intervention: IV-TXA group
Number of subjects: 84
Study: 24121915

Group type: EXPERIMENTAL
Intervention: Betamethasone (12 mg)
Number of subjects: 25

Group type: COMPARATOR
Intervention: Placebo (sterile saline solution)
Number of subjects: 25
Study: 22124602

Group type: EXPERIMENTAL
Intervention: Supervised physical therapy focusing on strengthening exercises of the rotator cuff and scapula stabilizers (PT-group)
Number of subjects: 36

Group type: COMPARATOR
Intervention: Home-based movement exercises (H-group)
Number of subjects: 36
Study: 20634797

Group type: EXPERIMENTAL
Intervention: Perindopril (8 mg/day)
Number of subjects: 19

Group type: EXPERIMENTAL
Intervention: Quinapril (40 mg/day)
Number of subjects: 19

Group type: EXPERIMENTAL
Intervention: Lisinopril (20 mg/day)
Number of subjects: 19

Group type: COMPARATOR
Intervention: Healthy control group
Number of subjects: 19
Study: 18070469

Group type: EXPERIMENTAL
Intervention: Transcatheter closure of atrial septal defect (ASD)
Number of subjects: 264

Group type: COMPARATOR
Intervention: Preoperative atrial tachyarrhythmias (AT)
Number of subjects: 264

Group type: EXPERIMENTAL
Intervention: Older age
Number of subjects: 264

Group type: EXPERIMENTAL
Intervention: Presence of preoperative AT
Number of subjects: 264

Group type: EXPERIMENTAL
Intervention: Left atrial enlargement
Number of subjects: 264
Study: 15223106

Group type: EXPERIMENTAL
Intervention: Oral estradiol valerate 2 mg per day plus normegestrol acetate 2.5 mg per day for 12 months
Number of subjects: 199

Group type: EXPERIMENTAL
Intervention: Transdermal estradiol (50 microg per day) plus normegestrol acetate 2.5 mg per day for 12 months
Number of subjects: 199

Group type: COMPARATOR
Intervention: Both groups (oral and transdermal)
Number of subjects: 199
Study: 11437864

Group type: EXPERIMENTAL
Intervention: Aquacel dressing (Group B)
Number of subjects: 20

Group type: COMPARATOR
Intervention: Saline-moistened gauze (Group A)
Number of subjects: 20
Study: 9679581

Group type: COMPARATOR
Intervention: UFT as adjuvant chemotherapy for bladder cancer (12 patients)
Number of subjects: 22

Group type: COMPARATOR
Intervention: UFT combined with endocrine therapy for prostate cancer (10 patients)
Number of subjects: 22
Study: 7852207

Group type: EXPERIMENTAL
Intervention: Acquirable skill condition
Number of subjects: 76

Group type: COMPARATOR
Intervention: Entity condition
Number of subjects: 76

Group type: EXPERIMENTAL
Intervention: Training intervention
Number of subjects: 76
Study: 2529028

Group type: EXPERIMENTAL
Intervention: 100 mg of HPR
Number of subjects: 14

Group type: EXPERIMENTAL
Intervention: 200 mg of HPR
Number of subjects: 14

Group type: EXPERIMENTAL
Intervention: 300 mg of HPR
Number of subjects: 14

Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 14
Study: 1100225

Group type: EXPERIMENTAL
Intervention: NSC-122819 (50 mg/m2/dose iv twice weekly for 4 weeks)
Number of subjects: 39

Group type: EXPERIMENTAL
Intervention: NSC-141540 (75 mg/m2/dose iv twice weekly for 4 weeks)
Number of subjects: 39

Group type: EXPERIMENTAL
Intervention: Both NSC-122819 and NSC-141540
Number of subjects: 39
Study: 31273569

Group type: EXPERIMENTAL
Intervention: Diode laser
Number of subjects: 30

Group type: COMPARATOR
Intervention: Electrocautery
Number of subjects: 30

Group type: COMPARATOR
Intervention: Scalpel
Number of subjects: 30
Study: 29728662

Group type: EXPERIMENTAL
Intervention: Central retinal arteriolar equivalents (CRAE) in men with a 20% shorter leukocyte telomere length (LTL)
Number of subjects: 168

Group type: EXPERIMENTAL
Intervention: Arteriole-to-venule ratio (AVR) in men with a 20% shorter leukocyte telomere length (LTL)
Number of subjects: 168

Group type: COMPARATOR
Intervention: Retinal microvascular traits in women
Number of subjects: 168
Study: 27398781

Group type: EXPERIMENTAL
Intervention: Brief advice intervention
Number of subjects: 217

Group type: EXPERIMENTAL
Intervention: MET + CBT
Number of subjects: 217

Group type: COMPARATOR
Intervention: Brief psychoeducation
Number of subjects: 217

Group type: COMPARATOR
Intervention: Control group (not specified)
Number of subjects: 217
Study: 24689339

Group type: EXPERIMENTAL
Intervention: Social norms feedback via personalised Facebook private messages over three sessions
Number of subjects: 95

Group type: COMPARATOR
Intervention: Control group (no intervention)
Number of subjects: 95
Study: 23598288

Group type: EXPERIMENTAL
Intervention: 0.9% saline infusion
Number of subjects: 25

Group type: COMPARATOR
Intervention: Plasmalyte infusion
Number of subjects: 25
Study: 20455959

Group type: EXPERIMENTAL
Intervention: Live maggots applied to wound cultures
Number of subjects: 0
Study: 17962237

Group type: EXPERIMENTAL
Intervention: CRx-102
Number of subjects: 83

Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 83
Study: 15347712

Group type: EXPERIMENTAL
Intervention: 123I-5IA SPECT imaging of nAChRs
Number of subjects: 0
Study: 11181464

Group type: EXPERIMENTAL
Intervention: Ramipril 2.5 mg/d
Number of subjects: 732

Group type: EXPERIMENTAL
Intervention: Ramipril 10 mg/d
Number of subjects: 732

Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 732

Group type: EXPERIMENTAL
Intervention: Vitamin E
Number of subjects: 732

Group type: COMPARATOR
Intervention: Placebo for Vitamin E
Number of subjects: 732
Study: 9835978

Group type: EXPERIMENTAL
Intervention: Continuous injection (CA) group, n = 21
Number of subjects: 42

Group type: COMPARATOR
Intervention: Patient-controlled analgesia (PCA) group, n = 21
Number of subjects: 42
Study: 8129127

Group type: EXPERIMENTAL
Intervention: Tonsillar infiltration with 0.25% bupivacaine 5 min before surgical incision (n = 12)
Number of subjects: 35

Group type: EXPERIMENTAL
Intervention: Tonsillar infiltration with 0.25% bupivacaine administered after both tonsils had been surgically removed (n = 12)
Number of subjects: 35

Group type: COMPARATOR
Intervention: Infiltration with isotonic saline 5 min before the operation (n = 11)
Number of subjects: 35

Group type: EXPERIMENTAL
Intervention: Pre-operative bupivacaine group (n = 12)
Number of subjects: 35

Group type: EXPERIMENTAL
Intervention: Postoperative bupivacaine group (n = 12)
Number of subjects: 35

Group type: COMPARATOR
Intervention: Saline group (n = 11)
Number of subjects: 35

Group type: EXPERIMENTAL
Intervention: All groups
Number of subjects: 35
Study: 2916912

Group type: EXPERIMENTAL
Intervention: Conventional back strengthening program consisting mainly of antigravity upper back extension exercises in the prone position.
Number of subjects: 50

Group type: COMPARATOR
Intervention: Usual athletic and daily physical activities (Control group).
Number of subjects: 50
Study: 4901344

Group type: EXPERIMENTAL
Intervention: Trimethoprim 320 mg and Sulphamethoxazole 1,600 mg a day
Number of subjects: 50

Group type: COMPARATOR
Intervention: Ampicillin 2 g a day
Number of subjects: 50
Study: 31953696

Group type: EXPERIMENTAL
Intervention: TCbHP (6 cycles)
Number of subjects: 204

Group type: EXPERIMENTAL
Intervention: TCbHP (4 cycles) followed by T-DM1+P (4 cycles)
Number of subjects: 204

Group type: EXPERIMENTAL
Intervention: T-DM1+P (4 cycles)
Number of subjects: 204

Group type: EXPERIMENTAL
Intervention: T-DM1+P (4 cycles) in responders
Number of subjects: 204

Group type: EXPERIMENTAL
Intervention: FEC (4 cycles) in nonresponders
Number of subjects: 204
Study: 30817246

Group type: EXPERIMENTAL
Intervention: Lower-body positive pressure (LBPP) at 40 mmHg when supine
Number of subjects: 22

Group type: EXPERIMENTAL
Intervention: LBPP plus 10° Trendelenburg position
Number of subjects: 22

Group type: EXPERIMENTAL
Intervention: Returning to supine with LBPP
Number of subjects: 22

Group type: COMPARATOR
Intervention: Control (laying supine for equal time)
Number of subjects: 22
Study: 28477490

Group type: EXPERIMENTAL
Intervention: Multifocal tumours
Number of subjects: 3338

Group type: COMPARATOR
Intervention: Unifocal tumours
Number of subjects: 3338
Study: 25147364

Group type: EXPERIMENTAL
Intervention: Intravenous lidocaine (2 mg/kg)
Number of subjects: 40

Group type: COMPARATOR
Intervention: Intravenous morphine (0.1 mg/kg)
Number of subjects: 40
Study: 23345634

Group type: EXPERIMENTAL
Intervention: Statin use in the acute phase after IV thrombolysis
Number of subjects: 2072
Study: 22032731

Group type: EXPERIMENTAL
Intervention: MLPA assay for predicting BRCAness
Number of subjects: 84

Group type: EXPERIMENTAL
Intervention: MLPA assay applied to independent validation set
Number of subjects: 84

Group type: EXPERIMENTAL
Intervention: MLPA test applied to 46 breast tumour samples from a randomized clinical trial
Number of subjects: 84
Study: 19253204

Group type: EXPERIMENTAL
Intervention: Sitagliptin 100 mg q.d.
Number of subjects: 80

Group type: EXPERIMENTAL
Intervention: Sitagliptin 50 mg b.i.d.
Number of subjects: 80

Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 80

Group type: EXPERIMENTAL
Intervention: Sitagliptin 100 mg q.d. and 50 mg b.i.d.
Number of subjects: 80
Study: 16633143

Group type: EXPERIMENTAL
Intervention: Reboxetine (8 mg/d)
Number of subjects: 40

Group type: COMPARATOR
Intervention: Fluvoxamine (150 mg/d)
Number of subjects: 40

Group type: EXPERIMENTAL
Intervention: Reboxetine
Number of subjects: 40

Group type: COMPARATOR
Intervention: Fluvoxamine
Number of subjects: 40
Study: 15283825

Group type: EXPERIMENTAL
Intervention: Rectal paracetamol (20‐25 mg x kg(‐1)) preoperatively
Number of subjects: 60

Group type: COMPARATOR
Intervention: Caudal bupivacaine
Number of subjects: 60

Group type: EXPERIMENTAL
Intervention: Rectal paracetamol (20‐25 mg x kg(‐1)) postoperatively
Number of subjects: 60
Study: 11419378

Group type: EXPERIMENTAL
Intervention: Special jury instructions not to discount awards for uncertainty about the defendant's fault
Number of subjects: 0

Group type: EXPERIMENTAL
Intervention: Special jury instructions not to increase awards to punish the defendant's carelessness
Number of subjects: 0

Group type: COMPARATOR
Intervention: Bifurcation of liability and compensation decisions
Number of subjects: 0

Group type: EXPERIMENTAL
Intervention: Discounting process
Number of subjects: 0
Study: 9244208

Group type: EXPERIMENTAL
Intervention: Pravastatin
Number of subjects: 69

Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 69
Study: 8386917

Group type: EXPERIMENTAL
Intervention: 4 mg nedocromil sodium four times daily for 12 weeks
Number of subjects: 209

Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 209

Group type: EXPERIMENTAL
Intervention: 4 mg nedocromil sodium
Number of subjects: 209
Study: 3122518

Group type: EXPERIMENTAL
Intervention: Mannitol administered 30 min prior to bypass
Number of subjects: 2

Group type: COMPARATOR
Intervention: Mannitol at the start of bypass (control group)
Number of subjects: 2
Study: 31977698

Group type: EXPERIMENTAL
Intervention: Submandibular anesthesia through catheter perfusion, lingual nerve block, and subcutaneous infiltration anesthesia
Number of subjects: 38

Group type: COMPARATOR
Intervention: Lingual nerve block and subcutaneous infiltration anesthesia
Number of subjects: 38
Study: 30132686

Group type: EXPERIMENTAL
Intervention: Pediatric Prolonged-Release Melatonin (PedPRM) 2/5 mg nightly for 39 weeks
Number of subjects: 95

Group type: COMPARATOR
Intervention: Pediatric Prolonged-Release Melatonin (PedPRM)
Number of subjects: 95
Study: 27566331

Group type: EXPERIMENTAL
Intervention: Targeting systolic blood pressure (SBP) <120 mmHg
Number of subjects: 0

Group type: COMPARATOR
Intervention: Targeting systolic blood pressure (SBP) <140 mmHg
Number of subjects: 0
Study: 24198051

Group type: EXPERIMENTAL
Intervention: Atorvastatin (5-10 mg for 3 months)
Number of subjects: 20

Group type: COMPARATOR
Intervention: Ezetimibe (10 mg for 3 months)
Number of subjects: 20
Study: 22510898

Group type: EXPERIMENTAL
Intervention: Autologous platelet‐leukocyte‐enriched plasma spray
Number of subjects: 12

Group type: COMPARATOR
Intervention: Control side (no treatment)
Number of subjects: 12
Study: 20149066

Group type: EXPERIMENTAL
Intervention: Trainees
Number of subjects: 128

Group type: EXPERIMENTAL
Intervention: Experienced Community Oral Health Workers (COHW)
Number of subjects: 128

Group type: EXPERIMENTAL
Intervention: Professional dentists
Number of subjects: 128
Study: 18545248

Group type: EXPERIMENTAL
Intervention: Allogeneic stem cell transplantation (SCT)
Number of subjects: 0

Group type: EXPERIMENTAL
Intervention: Prospective SCT trials
Number of subjects: 0
Study: 15205717

Group type: EXPERIMENTAL
Intervention: Atorvastatin, 20 mg per day (n=24)
Number of subjects: 49

Group type: COMPARATOR
Intervention: Matching placebos (n=25)
Number of subjects: 49
Study: 11723148

Group type: EXPERIMENTAL
Intervention: 125‐mg b.i.d. doses of levodopa/benserazide (Madopar)
Number of subjects: 17

Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 17
Study: 10325653

Group type: EXPERIMENTAL
Intervention: Nutritional knowledge, attitude and practice survey
Number of subjects: 965

Group type: EXPERIMENTAL
Intervention: Nutritional knowledge acquisition attitude
Number of subjects: 965

Group type: EXPERIMENTAL
Intervention: Food frequency survey
Number of subjects: 965

Group type: EXPERIMENTAL
Intervention: Sources of nutritional information
Number of subjects: 965
Study: 8267134

Group type: EXPERIMENTAL
Intervention: Haloperidol treatment (plasma levels varied, duration 6 weeks)
Number of subjects: 45
Study: 3438116

Group type: EXPERIMENTAL
Intervention: Kinesthetic instruction
Number of subjects: 20

Group type: COMPARATOR
Intervention: Visual instruction
Number of subjects: 20
Study: 31206569

Group type: COMPARATOR
Intervention: Mucoperiosteal harvesting technique (Group A)
Number of subjects: 20

Group type: EXPERIMENTAL
Intervention: Mucosal harvesting technique (Group B)
Number of subjects: 20

Group type: COMPARATOR
Intervention: Comparison between Group A and Group B
Number of subjects: 20
Study: 29442524

Group type: EXPERIMENTAL
Intervention: Acute Exacerbations of Chronic Obstructive Pulmonary Disease (AECOPD)
Number of subjects: 16485

Group type: EXPERIMENTAL
Intervention: Hospitalized AECOPD
Number of subjects: 16485
Study: 26930055

Group type: EXPERIMENTAL
Intervention: ASSIP (Attempted Suicide Short Intervention Program)
Number of subjects: 120

Group type: COMPARATOR
Intervention: Control (treatment as usual)
Number of subjects: 120
Study: 25443802

Group type: EXPERIMENTAL
Intervention: Cloud-based manometers integrated with physician order entry systems
Number of subjects: 36

Group type: COMPARATOR
Intervention: Typical BP recording sheets
Number of subjects: 36
Study: 22591589

Group type: EXPERIMENTAL
Intervention: Short‐course image‐guided radiotherapy (RT)
Number of subjects: 119

Group type: COMPARATOR
Intervention: Conventional radiotherapy (RT)
Number of subjects: 119

Group type: EXPERIMENTAL
Intervention: Pre-RT Scapula alata (SA)
Number of subjects: 119

Group type: EXPERIMENTAL
Intervention: Pre-RT characteristics
Number of subjects: 119
Study: 21126970

Group type: EXPERIMENTAL
Intervention: High vegetable consumption in childhood
Number of subjects: 1622

Group type: EXPERIMENTAL
Intervention: Persistently high consumption of fruits and vegetables from childhood to adulthood
Number of subjects: 1622

Group type: EXPERIMENTAL
Intervention: Number of lifestyle risk factors in childhood (lowest quintile for vegetable consumption, fruit consumption, physical activity, and smoking)
Number of subjects: 1622
Study: 17661330

Group type: EXPERIMENTAL
Intervention: Echinacea purpurea
Number of subjects: 0

Group type: EXPERIMENTAL
Intervention: Astragalus membranaceus
Number of subjects: 0

Group type: EXPERIMENTAL
Intervention: Glycyrrhiza glabra
Number of subjects: 0

Group type: EXPERIMENTAL
Intervention: Echinacea purpurea (daily use for at least 7 days)
Number of subjects: 0
Study: 15882217

Group type: EXPERIMENTAL
Intervention: 0.15% benzydamine hydrochloride and 0.05% cetylpyridinium chloride mouth rinse (BNZ+CPC)
Number of subjects: 0

Group type: COMPARATOR
Intervention: CPC mouth rinse
Number of subjects: 0

Group type: COMPARATOR
Intervention: Placebo mouth rinse
Number of subjects: 0
Study: 11050634

Group type: EXPERIMENTAL
Intervention: High-viscosity ferristene formulations
Number of subjects: 113

Group type: EXPERIMENTAL
Intervention: MRI
Number of subjects: 113

Group type: EXPERIMENTAL
Intervention: Double-contrast MRI
Number of subjects: 113
Study: 9329701

Group type: EXPERIMENTAL
Intervention: Propentofylline (3 x 300 mg taken 1 hr before food)
Number of subjects: 1260

Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 1260
Study: 8390009

Group type: EXPERIMENTAL
Intervention: Calcium acetate
Number of subjects: 15

Group type: COMPARATOR
Intervention: Calcium carbonate
Number of subjects: 15
Study: 3564873

Group type: EXPERIMENTAL
Intervention: Epidural bupivacaine (0.25%) continuously administered by infusion pump, 4‐6 ml h‐1, for 48 h
Number of subjects: 60

Group type: EXPERIMENTAL
Intervention: Epidural morphine, 2‐6 mg, at the end of operation and repeated on the first and second postoperative mornings
Number of subjects: 60

Group type: EXPERIMENTAL
Intervention: Epidural morphine, 2‐6 mg per die, administered for 48 h continuously by infusion pump
Number of subjects: 60

Group type: COMPARATOR
Intervention: Intramuscular oxycodone (0.15 mg kg‐1) on request
Number of subjects: 60
Study: 29617177

Group type: EXPERIMENTAL
Intervention: Live attenuated influenza vaccine
Number of subjects: 0

Group type: EXPERIMENTAL
Intervention: Inactivated influenza vaccine
Number of subjects: 0

Group type: COMPARATOR
Intervention: Control group not specified
Number of subjects: 0
Study: 28198712

Group type: EXPERIMENTAL
Intervention: Antiretroviral therapy (ART)
Number of subjects: 0
Study: 25011643

Group type: EXPERIMENTAL
Intervention: Thrombin-based topical haemostatic agent (Floseal)
Number of subjects: 48

Group type: COMPARATOR
Intervention: Standard treatment (control)
Number of subjects: 48